Friday, May 7, 2021

Karen Johnson

Karen Johnson
Karen has been writing for more than two decades and her work has been featured in various mediums, including newspapers, journals, digital magazines, and blogs. She went on to pursue a Doctorate in Physical Therapy. The rigorous nature of her doctoral candidacy proved to be extremely valuable to Karen as a way to refine her medical research skills and writing efficiency. As Medical News Editor, Karen leads a team of passionate writers and editors, who work collectively to bring you the latest medical news and information.


Merck & Co. has announced that it has recovered FDA approval for its drug Keytruda (pembrolizumab) in combination with other drugs for the treatment of HER2 positive gastroesophageal adenocarcinoma. The FDA granted accelerated approval on May 5, 2020.
An Illinois woman believes that her husband, who died by suicide, was actually suffering from what some mental health experts call “COVID Psychosis.” This neurological and psychological condition is related to COVID-19, which could be due to brain inflammation or side effects of steroids, low oxygen levels, or emotional trauma of severe illness.
New research has found that short-term exposure to air pollution affects cognition or mental performance, but these effects were reduced after taking non-steroidal anti-inflammatory drugs (NSAIDs), especially aspirin. However, the study did not find a direct link between NSAID use and cognitive performance.
New German research has found that a combination of diabetes and COVID-19 could be deadly. The study found that the severity of diabetes or poorly controlled diabetes increases the risk of death in people with diabetes and COVID-19. The study was published in the journal Diabetologia.
Researchers of the University of Texas have been investigating motor impairments in children with autisms for over a year now. They are studying the motor skills in children with autism spectrum disorder (ASD) using a real-time 3D animation.

Recent Posts